NYS Association of Occupational Health Nurses
Stay Connected
Become a member

HHS and CDC Recommendations to Expand the Use of Naloxone - Free Webinar

Posted about 6 years ago

Overview

About 48,000 drug overdose deaths involved opioids in the United States in 2017. Naloxone is a life-saving drug that can reverse the effects of an opioid overdose. Despite recent progress in naloxone dispensing, naloxone remains under-prescribed and underused, often in a variable pattern. Healthcare providers and pharmacists play a critical role in ensuring patients receive naloxone, as they have a frontline view and can make progress in prescribing and dispensing of naloxone. The 2016 CDC Guideline for Prescribing Opioids for Chronic Pain recommends that healthcare providers consider prescribing or dispensing naloxone to patients at risk for overdose.

During this COCA Call, clinicians will learn about HHS and CDC recommendations for the prescribing or dispensing of naloxone to patients at risk for opioid overdose.

This call will discuss topics covered in the Vital Signs MMWR from August 2019 “Life-Saving Naloxone from Pharmacies."

Date: Tuesday, September 17, 2019

Time: 2:00pm–3:00pm (ET)

A few minutes before the webinar begins, please click the link below to join:
https://zoom.us/j/996942494 

Or iPhone one-tap:
US: +16468769923,,996942494# or +16699006833,,996942494#

 

Or Telephone:
US: +1 646 876 9923 or +1 669 900 6833

Webinar ID: 996 942 494

International numbers are available here:
https://zoom.us/u/anixAVglV

If you are unable to attend this live COCA Call, it will be available to view on-demand a few days after the call.

Free continuing education (CE) is available for this COCA Call. Please see below for instructions on how to receive CE.

Activity-specific Objectives

At the conclusion of the session, the participant will be able to accomplish the following:

  1. Identify the risk factors for opioid overdose.
  2. Promote the CDC Guideline recommendations and the Department of Health and Human Services (HHS) guidance on naloxone co-prescribing.
  3. Describe the history of naloxone use and current state-level policies.
  4. Discuss the steps that can be taken to link survivors of opioid overdose to treatment.
  5. Describe actions that can help expand naloxone access at the local level.

COCA Call Objectives

At the conclusion of the session, the participant will be able to accomplish the following:

  1. Cite background information on the topic covered during the presentation.
  2. Discuss CDC’s role in the topic covered during the presentation.
  3. Describe the topic’s implications for clinicians.
  4. Discuss concerns and/or issues related to preparedness for and/or response to urgent public health threats.
  5. Promote health improvement, wellness, and disease prevention in cooperation with patients, communities, at-risk populations, and other members of an interprofessional team of health care providers.

Presenters

Vice Admiral Jerome M. Adams, MD, MPH (USPHS)
20th U.S. Surgeon General

Christopher M. Jones, PharmD, DrPH, MPH (USPHS)
National Center for Injury Prevention and Control
Centers for Disease Control and Prevention

Instructions for Obtaining Continuing Education (CE)

To receive continuing education (CE) for WC2922-091719 – (Webcast) Clinician Outreach and Communication Activity (COCA) Calls/Webinars – COCA Call: "HHS and CDC Recommendations to Expand the Use of Naloxone—A Life-saving, yet Underutilized Drug for Reversing Opioid Overdose", September 17, 2019, please visit TCEO and follow these 9 Simple Steps by October 21, 2019.

To receive continuing education (CE) for WD2922-091719 – Clinician Outreach and Communication Activity (COCA) Calls/Webinars – COCA Call: "HHS and CDC Recommendations to Expand the Use of Naloxone—A Life-saving, yet Underutilized Drug for Reversing Opioid Overdose", September 17, 2019 (Web on Demand), please visit TCEO and follow these 9 Simple Steps by October 22, 2021.